file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
2201 | GRAFT-VS | 2 | 3 | 27 |
2202 | HETEROPHIL | 1 | 1 | 27 |
2203 | IMMUNOHISTOLOGICAL | 1 | 5 | 27 |
2204 | KILLING | 2 | 0 | 27 |
2205 | LIPOSOMAL | 3 | 1 | 27 |
2206 | LYMPHOCYTOTOXIC | 2 | 2 | 27 |
2207 | LYMPHOCYTURIA | 1 | 1 | 27 |
2208 | LYSOZYMURIA | 1 | 1 | 27 |
2209 | MUSCLE | 3 | 0 | 27 |
2210 | NEUROREGENERATION | 1 | 2 | 27 |
2211 | NON-HISTOCOMPATIBILITY | 1 | 3 | 27 |
2212 | NONLYMPHOID | 1 | 24 | 27 |
2213 | NONTRANSPLANTED | 1 | 8 | 27 |
2214 | PARADOXICAL | 1 | 12 | 27 |
2215 | PRECURSORS | 2 | 2 | 27 |
2216 | PREFORMED | 4 | 6 | 27 |
2217 | PRIMERS | 1 | 11 | 27 |
2218 | PROMISING | 1 | 3 | 27 |
2219 | REGENERATIVE | 1 | 2 | 27 |
2220 | T-SUPPRESSOR | 1 | 11 | 27 |
2221 | TALE | 1 | 11 | 27 |
2222 | TOLERIZE | 1 | 1 | 27 |
2223 | TOLEROGENICITY | 2 | 7 | 27 |
2224 | TYPE-I | 2 | 0 | 27 |
2225 | WIDE | 1 | 3 | 27 |
2226 | WILL | 2 | 6 | 27 |
2227 | ADENOVIRAL | 2 | 2 | 26 |
2228 | ANTI-INTERLEUKIN-2 | 1 | 1 | 26 |
2229 | ANTIBODY-PRODUCTION | 3 | 3 | 26 |
2230 | ATTENUATES | 1 | 1 | 26 |
# | Word | Recs | TLCS | TGCS |
2231 | BENCH | 1 | 1 | 26 |
2232 | FIVE-YEAR | 1 | 2 | 26 |
2233 | FKBP-12 | 1 | 2 | 26 |
2234 | GENERAL | 4 | 0 | 26 |
2235 | INTRACTABLE | 2 | 7 | 26 |
2236 | LYMPHO-PROLIFERATIVE | 1 | 1 | 26 |
2237 | MALFUNCTION | 1 | 4 | 26 |
2238 | MICROSOME | 1 | 9 | 26 |
2239 | PEDIATRIC-PATIENT | 1 | 1 | 26 |
2240 | POSTNATAL | 2 | 1 | 26 |
2241 | POSTSTORAGE | 1 | 0 | 26 |
2242 | PREDOMINANT | 2 | 0 | 26 |
2243 | PRESTORAGE | 1 | 0 | 26 |
2244 | PROMISE | 2 | 8 | 26 |
2245 | REQUIREMENT | 3 | 11 | 26 |
2246 | REVERSES | 1 | 6 | 26 |
2247 | STAGING | 1 | 2 | 26 |
2248 | STROKE | 1 | 1 | 26 |
2249 | TIBIAL | 1 | 2 | 26 |
2250 | VERTEBRAL | 5 | 7 | 26 |
2251 | VIRUS-ASSOCIATED | 1 | 1 | 26 |
2252 | 12-KD | 1 | 1 | 25 |
2253 | 31-O-DESMETHYLFK-506 | 1 | 1 | 25 |
2254 | ABO-COMPATIBLE | 1 | 0 | 25 |
2255 | ACHIEVED | 3 | 1 | 25 |
2256 | ADAPTATION | 1 | 0 | 25 |
2257 | ANTIBODY-MEDIATED | 1 | 0 | 25 |
2258 | ANTIRENAL | 1 | 0 | 25 |
2259 | ATTEMPTED | 1 | 7 | 25 |
2260 | BB-RATS | 1 | 5 | 25 |
# | Word | Recs | TLCS | TGCS |
2261 | BIOSYNTHESIS | 1 | 1 | 25 |
2262 | CD40IG | 1 | 1 | 25 |
2263 | CELL-DERIVED | 2 | 12 | 25 |
2264 | CONTACT | 1 | 0 | 25 |
2265 | DECREASE | 1 | 3 | 25 |
2266 | DONOR-REACTIVE | 1 | 3 | 25 |
2267 | ENZYMOLOGY | 1 | 1 | 25 |
2268 | ERYTHROPOIESIS | 2 | 1 | 25 |
2269 | EXOCRINE | 2 | 3 | 25 |
2270 | FORSSMAN | 1 | 0 | 25 |
2271 | FUNCTIONS | 3 | 0 | 25 |
2272 | GENETICS | 1 | 0 | 25 |
2273 | GOOD | 2 | 5 | 25 |
2274 | GRANULOCYTES | 1 | 0 | 25 |
2275 | GUINEA-PIGS | 1 | 0 | 25 |
2276 | HETEROGENEITY | 1 | 1 | 25 |
2277 | HLA-DR | 2 | 8 | 25 |
2278 | IMMUNOFLUORESCENCE | 2 | 1 | 25 |
2279 | INCOMPATIBILITY | 2 | 0 | 25 |
2280 | INFILTRATING | 2 | 0 | 25 |
2281 | INFLUENCING | 4 | 1 | 25 |
2282 | INHIBITOR-2 | 1 | 1 | 25 |
2283 | INJECTIONS | 1 | 2 | 25 |
2284 | IRON | 1 | 4 | 25 |
2285 | JAPANESE | 3 | 4 | 25 |
2286 | LIKELY | 1 | 1 | 25 |
2287 | MA6858 | 1 | 1 | 25 |
2288 | NEONATAL | 5 | 0 | 25 |
2289 | NEUTROPHILIC | 1 | 0 | 25 |
2290 | O-METHYLTRANSFERASE | 1 | 1 | 25 |
# | Word | Recs | TLCS | TGCS |
2291 | OBSTRUCTION | 2 | 0 | 25 |
2292 | PCR-BASED | 2 | 8 | 25 |
2293 | PRESSURE | 2 | 3 | 25 |
2294 | PROTEIN-KINASE-C | 1 | 1 | 25 |
2295 | SINGLE-DAY | 1 | 7 | 25 |
2296 | STREPTOMYCES | 1 | 1 | 25 |
2297 | SUBSETS | 3 | 0 | 25 |
2298 | UNDERLYING | 2 | 2 | 25 |
2299 | 31-YEAR | 2 | 0 | 24 |
2300 | ACUTE-PANCREATITIS | 2 | 3 | 24 |
2301 | AHLS | 1 | 6 | 24 |
2302 | AUTOPSIED | 1 | 0 | 24 |
2303 | BILATERAL-NEPHRECTOMY | 1 | 0 | 24 |
2304 | CLINICIAN | 1 | 0 | 24 |
2305 | COSMAS | 1 | 7 | 24 |
2306 | DAMIAN | 1 | 7 | 24 |
2307 | DELIVERY | 3 | 0 | 24 |
2308 | DEPOSITS | 1 | 6 | 24 |
2309 | DISCLOSED | 1 | 0 | 24 |
2310 | DNA-BINDING | 1 | 3 | 24 |
2311 | ERYTHROCYTES | 2 | 9 | 24 |
2312 | FIBRINOGEN | 1 | 1 | 24 |
2313 | FRACTIONAL | 2 | 0 | 24 |
2314 | GALECTIN-1 | 2 | 1 | 24 |
2315 | IMMUNOGLOBULIN-G | 1 | 6 | 24 |
2316 | IMMUNOLOGICAL-TOLERANCE | 4 | 13 | 24 |
2317 | IMPORTANT | 2 | 0 | 24 |
2318 | INGUINAL | 1 | 0 | 24 |
2319 | ISLAND | 1 | 0 | 24 |
2320 | KNOW | 1 | 0 | 24 |
# | Word | Recs | TLCS | TGCS |
2321 | LEUCOCYTES | 1 | 7 | 24 |
2322 | MANSONI-INFECTED | 1 | 0 | 24 |
2323 | MUSCULOSKELETAL | 1 | 8 | 24 |
2324 | NEGLECT | 1 | 7 | 24 |
2325 | NEPHRITIS | 2 | 6 | 24 |
2326 | NUCLEAR | 1 | 3 | 24 |
2327 | OFFERS | 1 | 0 | 24 |
2328 | PHARMACODYNAMIC | 2 | 0 | 24 |
2329 | PHENOTYPES | 2 | 0 | 24 |
2330 | PLACENTA | 1 | 0 | 24 |
2331 | PREFACE | 1 | 7 | 24 |
2332 | PROLIFERATIVE | 3 | 1 | 24 |
2333 | REFLECTIONS | 3 | 2 | 24 |
2334 | REGENERATING | 1 | 3 | 24 |
2335 | SCHISTOSOMA | 1 | 0 | 24 |
2336 | STOMATITIS | 1 | 6 | 24 |
2337 | STRANGER | 1 | 0 | 24 |
2338 | SUBSTANCES | 1 | 0 | 24 |
2339 | TACROLISMUS | 1 | 3 | 24 |
2340 | TISSUE-SPECIFIC | 1 | 6 | 24 |
2341 | TRANSDIFFERENTIATION | 1 | 3 | 24 |
2342 | URETERIC | 1 | 0 | 24 |
2343 | VESICULAR | 1 | 6 | 24 |
2344 | ALGORITHMS | 1 | 0 | 23 |
2345 | ALLOSPECIFIC | 1 | 1 | 23 |
2346 | ANTI-D | 1 | 3 | 23 |
2347 | ANTIBODY-DEPENDENT | 1 | 6 | 23 |
2348 | ANTILUMPHOCYTE | 1 | 4 | 23 |
2349 | BETA | 2 | 2 | 23 |
2350 | C-10-C-19 | 1 | 2 | 23 |
# | Word | Recs | TLCS | TGCS |
2351 | CHEMOENZYMATIC | 1 | 2 | 23 |
2352 | CHRONIC-RENAL-FAILURE | 1 | 0 | 23 |
2353 | CROHNS-DISEASE | 1 | 0 | 23 |
2354 | DERIVATIVE | 1 | 1 | 23 |
2355 | ELIMINATION | 2 | 3 | 23 |
2356 | ESTABLISH | 3 | 5 | 23 |
2357 | ESTIMATING | 1 | 15 | 23 |
2358 | FOE | 1 | 0 | 23 |
2359 | FRIEND | 1 | 0 | 23 |
2360 | FULL | 2 | 4 | 23 |
2361 | GRAFT-INFILTRATING | 2 | 3 | 23 |
2362 | GROUP-SPECIFIC | 1 | 9 | 23 |
2363 | HAEMAGGLUTINATING | 1 | 1 | 23 |
2364 | HETEROGRAFTED | 1 | 1 | 23 |
2365 | HETEROLOGUE | 1 | 5 | 23 |
2366 | HPCS | 1 | 0 | 23 |
2367 | IIIB | 1 | 0 | 23 |
2368 | IMPLANTATION | 3 | 4 | 23 |
2369 | IMPROVE | 2 | 2 | 23 |
2370 | LATENT | 1 | 6 | 23 |
2371 | LIGAND-MEDIATED | 1 | 1 | 23 |
2372 | LYMPHOMAS | 2 | 1 | 23 |
2373 | MALIGNANCIES | 2 | 3 | 23 |
2374 | MOIETY | 1 | 2 | 23 |
2375 | MYELIN | 1 | 1 | 23 |
2376 | NONIMMUNOSUPPRESSANT | 1 | 1 | 23 |
2377 | OBTAINING | 1 | 5 | 23 |
2378 | ONE-AND | 1 | 2 | 23 |
2379 | OPTIMISATION | 1 | 0 | 23 |
2380 | OVERGROWTHS | 1 | 1 | 23 |
# | Word | Recs | TLCS | TGCS |
2381 | PHASE-II | 1 | 4 | 23 |
2382 | PHASE-III | 1 | 2 | 23 |
2383 | PREDNISOLONE-SPECIFIC | 1 | 0 | 23 |
2384 | PREPARED | 1 | 2 | 23 |
2385 | RECIPROCAL | 2 | 8 | 23 |
2386 | RELAPSE | 1 | 0 | 23 |
2387 | S-ANTIGEN | 1 | 7 | 23 |
2388 | SEMIALLOGENEIC | 2 | 1 | 23 |
2389 | SERUMS | 1 | 5 | 23 |
2390 | SEX-DETERMINING | 1 | 15 | 23 |
2391 | SPECIFICITY | 1 | 2 | 23 |
2392 | TESTICULAR | 1 | 1 | 23 |
2393 | TNF | 1 | 1 | 23 |
2394 | TUBULAR-NECROSIS | 1 | 2 | 23 |
2395 | TWO-YEAR | 1 | 2 | 23 |
2396 | ALLOANTIBODY-MEDIATED | 1 | 1 | 22 |
2397 | BALTIMORE | 1 | 7 | 22 |
2398 | BEHCETS | 1 | 0 | 22 |
2399 | C16-C23 | 1 | 2 | 22 |
2400 | CARCINOGENESIS | 1 | 0 | 22 |